Uganda (Phillips, Fernandes, Pirani, and Wagaine, 1969;  Arya and Phillips, 1970; Arya, Pearson, Rao, and Blowers, 1970) . About 80 per cent. of gonococcal strains from the Kampala area show diminished sensitivity to penicillin at the present time, and such strains also exhibit slightly diminished sensitivity to tetracycline and total resistance to streptomycin (Phillips and others, 1969; Arya and Phillips, 1970) . Phillips and others (1969) also observed links in the sensitivity pattern between penicillin and other unrelated antibiotics-notably erythromycin, chloramphenicol, and gentamycin. Similar links have also been described elsewhere (Reyn and Bentzon, 1968, 1969; Phillips, Rimmer, Ridley, Lynn, and Warren, 1970) .
If conditions and practices responsible for the decline in usefulness of penicillin and other drugs are allowed to continue, then we may be 'witnessing the emergence of a multiple-resistant gonococcus' (Phillips and others, 1969) at least in this part of the world with a very high incidence of gonorrhoea. Moreover we are already reaching the limit of the amount of procaine penicillin (2-4 mega units) that can reasonably be given in one injection.
For these reasons it is important to search for alternative drugs. Rifadin (rifampicin), a semisynthetic oral antibiotic, has already been reported to give satisfactory results (Willcox, Morrison, and Cobbold, 1970) , and no toxic effects were reported with the dosage used. It was therefore decided to evaluate this drug in a population with a high incidence of gonorrhoea and very amenable to follow up (Arya and Phillips, 1970 of the urine which would be produced by the drug. Procaine penicillin (Flopen-Hoechst) 2-4 mega units intramuscularly in one dose was used in control casesthis being the routine treatment of gonorrhoea in the student clinic. The patients were randomly allocated to one of these treatment schedules. A few patients were also treated with eight capsules of Rifadin (1,200 mg.) given in a single dose.
FOLLOW-UP
Return visits were arranged 3 days, 1 week, 2 weeks, 3 weeks, and 3 months after treatment. Most patients were seen early in the moming, having held their urine all night, and the rest were seen later in the day after urine had been held for at least 3 hours. At each visit, after questioning about re-exposure and after clinical examination, any discharge was sampled and examined bacteriologically; two-glass urine tests were performed and the urine was examined for haze and threads; a Gramstained smear was made of the threads ifpresent. Prostatic massage was done only if symptoms or signs warranted it. If a patient failed to attend within 2 weeks, a letter was sent to him or he was visited in his room and later seen in the clinic as well. If all was well after 3 weeks, the patient was asked to return at the end of 3 months for final tests, but to come earlier if necessary. Some who attended earlier for other complaints were checked for venereal disease as well.
Patients in whom infection failed to respond to one treatment schedule were treated with the other schedule, or with Rifadin 1,200 mg. (i.e. eight capsules), or some other drug known to be effective.
Results
Of 327 episodes of urethritis seen in this study, 203 were diagnosed as cases of gonorrhoea. Of these 164 were seen within 2 days after the appearance of discharge, 37 within 3 to 6 days, and two after 7 days. Sources of infection were casual acquaintances or prostitutes in 104 cases, continuing acquaintance or friend in 84, wife in five, and a male friend in one case; in the remaining nine cases the source of infection could not be determined because multiple contacts had taken place within the space of a few days. Ten patients had previously been treated elsewhere (including self-treatment in two cases). Of the 169 patients who contracted these 203 attacks of gonorrhoea, fourteen were married.
FOLLOW-UP
Data on follow-up are given in Table I . About 60 per cent. of cases were followed up for more than 4 weeks. Most of the shorter periods of follow-up were seen in students who were re-infected. Almost onethird of re-infections had taken place within 4 weeks. The thirteen patients followed for less than 2 weeks include ten who were considered to be re-infected after having admitted to re-exposure; the remaining three were lost to the study, having left the university soon after treatment. From the 203 cases diagnosed as gonorrhoea during the clinical trial, 146 cultures were made, of which 125 were positive (only three of these had negative smears); 84 unselected cultures of the gonococcus were tested for penicillin sensitivity, and 69 (82 per cent.) showed diminished sensitivity (Table II) -a figure which is very similar to those reported earlier (Arya and Phillips, 1970; Arya and others, 1970 ). 112 strains were tested for sensitivity to Rifadin by the disc-diffusion method; all except one were sensitive, and this one was later reported to be sensitive after having been flown to Italy for further tests (Gruppo Lepetit, personal communication).
The infection caused by this strain did not respond to the Rifadin schedule of 900 mg. Three of the remaining cases of failure were treated and cured with a combination of procaine penicillin 2 4 m.u. in one injection, and lg. Ampicilin (Penbritin, Beecham Research Laboratories) given orally at the same time.
Discussion
Our criteria for defining failure and distinguishing relapse from reinfection were same as have been described earlier (Arya and Phillips, 1970; Arya and others, 1970) . Of the 23 cases of failure seen in this study, twenty were seen in the first week and the remaining three in the second week. Similar observations were made in the studies just quoted. Ten cases considered to be due to re-infection within 2 weeks on the basis of history of re-exposure were classed neither as failures nor as cures.
Although the makers have recommended that Rifadin should be administered on an empty stomach to ensure rapid and complete absorption (Lepetit, 1968) it was not always possible to do this. The drug was administered as soon as the diagnosis of gonorrhoea was made. As Table V One of these patients developed a sore one week after Rifadin treatment, had intercourse again (while the sore was present) and acquired another attack of gonorrhoea for which he again received Rifadin 900 mg. Although advised to report for darkfield examination, he did not return until 10 days later when the sore had increased in size; a darkfield examination done at this time showed a large number of Treponema pallidum organisms. His serum tests for syphilis which were negative when the sore was first seen had become positive at the subsequent visit 10 days later.
The second patient presented himself 8 weeks after treatment with Rifadin with a typical syphilitic penile chancre of at least 2 weeks' duration and enlargement of regional lymph glands. He denied any further sexual exposure. Darkground examination showed Treponema pallidum and serum tests for syphilis were also positive, having been negative when he first reported.
More elaborate observations in this connection have been made by Fuga and Gentili (1968) .
However, in view of its potential in the treatment of tuberculosis, it is suggested that Rifadin should not be used routinely for the treatment of gonorrhoea 
